Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Top Headlines

Horizon Europe’s €100bn budget receives endorsement

Industry welcomes the European Parliament’s decision to endorse the provisional funding agreement for Horizon Europe.

WuXi and I-Mab extend partnership to accelerate biologic development

I-Mab and WuXi Biologics extend their strategic partnership for biologics process development as well as clinical and commercial manufacturing to accelerate drug development in China and abroad.

Regenerative medicine market to triple to $38.7bn by 2024

The regenerative medicine market is predicted to develop at a CAGR of 23.8%, driven by the growing cell-based immunotherapy sector.

Roche revises sales expectations upwards on uptake of biologics

Despite increased competition from biosimilars in Europe, Roche announces sales of its pharmaceutical divisions are up by 10%.

Kiadis gains NK-cell technology for immunology therapies through CytoSen acquisition

Kiadis Pharma acquires CytoSen Therapeutics and gains NK-cell technology capabilities to complement its own T-cell platform.

Global Industry News

Hot Topics

Spotlight

Alvotech provides Stelara biosimilar supply to Fuji Pharma

Catalent’s $1.2bn Paragon deal sign of booming gene therapy market

Finding treatment solutions where there are none

Selexis’ biologic platform generates first-ever approved Soliris biosimilar

BeiGene pays $270m for PD-1 antibody boosting drug

Products

Webinars

On-demand webinars

Marken: Global Life Science Supply Chain Solutions Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor

Featured Suppliers

All suppliers

Baxter BioPharma Solutions

Bio-Rad Laboratories

Marken: Global Life Science Supply Chain Solutions

Merck KGaA, Darmstadt, Germany

Samsung BioLogics